Cello Health Insight US restructures senior operations team

pharmafield logo - pharma news

Cello Health Insight US has announced a reorganisation of the company’s senior operations.

Kathryn Gallant (pictured) has been appointed CEO of Cello Health Insight US and Angie Wheeler has been appointed President of Cello Health Insight, with immediate effect.

Gallant will take on overall responsibility for the growth of Cello Health Insight across the US, focussing in particular on building the US international revenue stream.

In addition to leading the Chicago office, Wheeler will take overall responsibility for building Cello Health Insight’s US domestic market business. 

In addition, the senior client-facing team sees the hiring of Justine Trinidad, Ed Geiselhart and Kaity Arctander.

Trinidad joins as the newest US director of ‘IQ,’ Cello Health Insight’s specialist quantitative research practice. With 20 years of marketing research experience, she brings a specialty in thoughtful, innovative quantitative research and analysis and clarity to complex questions.

Geiselhart, a Chicago-based director, has extensive experience in device design. He joins the team from Insight Product Development, where he was the Director of User Experience and Innovation.

Arctander joins after completing four years at Verilogue Inc., where she received the ‘President’s Award’ for contributions to innovative research methods. Based in Philadelphia, Arctander will help to expand the Cello Health Insight expert offering with her specialist knowledge in healthcare discourse and implications for behaviours in health.

Jane Shirley, CEO Cello Health Insight, said: “Kathryn and Angie have worked in partnership, with great success for many years to build Cello Health Insight, US. This development in their roles combined with the new additions opens up further leadership opportunities for the team and truly supports our ability to drive growth and expand the business.”